Preventive and unlimited Corrective Repair (Essentialcare or equal) service agreement for a Surface Plasmon Resonance (SPR) Biacore T200 instrument, Base plus two (2) option years

Closed Solicitation Posted

Solicitation number
75F40126Q135706
Agency
Responses due
Set-aside
No set-aside

Opportunity facts

Notice details come from SAM.gov. Updated .

About this opportunity

The FDA Office of Acquisition and Grant Services seeks preventive maintenance and unlimited corrective repair services for a Surface Plasmon Resonance Biacore T200 instrument, with proposals due August 10, 2026 at 2:00 PM Central Time. The procurement is full and open competition with no set-aside.

Place of performance is the FDA Center for Biologics Evaluation and Research facility in Silver Spring, Maryland. The contract covers a base year (August 30, 2026 through August 29, 2027) plus two optional one-year extension periods. As of the August 5, 2026 amendment, the requirement includes one annual preventive maintenance visit per contract year with comprehensive diagnostics and component replacement, and unlimited on-site corrective maintenance with an 8-hour remote response window and three-business-day on-site response for unresolved issues. All work must comply with OEM specifications using OEM-certified parts, with detailed service reports required after each visit.

The NAICS code is 811210, Electronic and Precision Equipment Repair and Maintenance, with a $34 million size standard. PSC is J066, Maint/Repair/Rebuild Of Equipment. Pricing is firm fixed-price on a monthly basis with payment terms of Net 30 days after government acceptance. Quotes must include technical capability demonstration, past performance references within the last three years, a Letter of Commitment from the OEM or subcontractor if applicable, pricing for all three line items, UEI number, and an Accessibility Conformance Report addressing HHSAR provision 352.239-78 and clause 352.239-79 for Section 508 compliance. Evaluation weighs technical capability and past performance collectively as more important than price. Quotations must reference solicitation number 75F40126Q135706 and be submitted by email to Suzanne Martella at suzanne.martella@fda.hhs.gov.

Notice text

3 versions

Update #3 · Latest ·

UPDATE 08/05/2026: This update is to post an Amendment (A00001) which removes "Unlimited Corrective Repairs" from the requirement, and also: 1) removes FAR clause 52.219-6 Notice of Small Business Set-Aside from the document as this is solicited full and open (as per page 1 of the solicitation--see question #1 below); 2) updates the solicitation number from 75F40126Q134706 to 75F40126Q135706 (internal to the document only) (see question #2, below); 3) corrects the HHSAR clause within the requirement for the Accessibility Conformance Report (ACR) from 352.239-74 to 352.329-79.

This RFQ is reopened until 08/10/2026 at 2:00pm Central time. 

UPDATE, Questions and Responses, 08/03/2026:

NOTE 1: Closing date and time is not affected by the issuance of the following Questions and Answers.

Note 2: No correcting documents are uploaded with this update. 

Vendor Question 1: Page 1 states that the acquisition is full and open and that businesses of any size may submit, while page 4 includes FAR 52.219-6, Notice of Total Small Business Set-Aside. Which competition status governs?

Government's Response: The acquisition is conducted on a full and open, unrestricted basis. Businesses of any size may submit a quotation. FAR 52.219-6 was included in error and is hereby removed from the solicitation.

Vendor Question 2: The SAM.gov notice details identify solicitation 75F40126Q135706, while the attached RFQ and its submission instruction identify 75F40126Q134706. Which solicitation number governs?

Government's Response: The correct solicitation number is 75F40126Q135706. The number listed on the attached RFQ document was a typographical error. All quotations submitted in response to this requirement must reference solicitation number 75F40126Q135706.

Vendor Question 3: Page 11 directs the Accessibility Conformance Report to standards identified in 352.239-74, while pages 9–10 identify 352.239-78 and 352.239-79 as the ICT accessibility provisions. Which clause or clauses should the report address?

Government's Response: The Information and Communication Technology (ICT) accessibility requirements for this solicitation are governed by provision HHSAR 352.239-78 (page 9 of the solicitation) and clause HHSAR 352.239-79(page 5 of the solicitation) as detailed within the provision and clause listed in the pages just referenced. The reference to 352.239-74 on page 11 was a template holdover. Offerors must ensure their Accessibility Conformance Report (ACR) addresses the active standards identified in provision 352.239-78 and clause HHSAR 352.239-79.

*****End of Questions and Answers****

ORIGINAL POSTING 07/27/2026: See attached Solicitation/Request for Quote (RFQ) for the FDA's requirement for a preventive and unlimited Corrective Repair (Essentialcare or equal) service agreement for a Surface Plasmon Resonance (SPR) Biacore T200 instrument for a Base plus two (2) option years

Update #2 ·

UPDATE, Questions and Responses, 08/03/2026:

NOTE 1: Closing date and time is not affected by the issuance of the following Questions and Answers.

Note 2: No correcting documents are uploaded with this update. 

Vendor Question 1: Page 1 states that the acquisition is full and open and that businesses of any size may submit, while page 4 includes FAR 52.219-6, Notice of Total Small Business Set-Aside. Which competition status governs?

Government's Response: The acquisition is conducted on a full and open, unrestricted basis. Businesses of any size may submit a quotation. FAR 52.219-6 was included in error and is hereby removed from the solicitation.

Vendor Question 2: The SAM.gov notice details identify solicitation 75F40126Q135706, while the attached RFQ and its submission instruction identify 75F40126Q134706. Which solicitation number governs?

Government's Response: The correct solicitation number is 75F40126Q135706. The number listed on the attached RFQ document was a typographical error. All quotations submitted in response to this requirement must reference solicitation number 75F40126Q135706.

Vendor Question 3: Page 11 directs the Accessibility Conformance Report to standards identified in 352.239-74, while pages 9–10 identify 352.239-78 and 352.239-79 as the ICT accessibility provisions. Which clause or clauses should the report address?

Government's Response: The Information and Communication Technology (ICT) accessibility requirements for this solicitation are governed by provision HHSAR 352.239-78 (page 9 of the solicitation) and clause HHSAR 352.239-79(page 5 of the solicitation) as detailed within the provision and clause listed in the pages just referenced. The reference to 352.239-74 on page 11 was a template holdover. Offerors must ensure their Accessibility Conformance Report (ACR) addresses the active standards identified in provision 352.239-78 and clause HHSAR 352.239-79.

*****End of Questions and Answers****

ORIGINAL POSTING 07/27/2026: See attached Solicitation/Request for Quote (RFQ) for the FDA's requirement for a preventive and unlimited Corrective Repair (Essentialcare or equal) service agreement for a Surface Plasmon Resonance (SPR) Biacore T200 instrument for a Base plus two (2) option years

Update #1 ·

See attached Solicitation/Request for Quote (RFQ) for the FDA's requirement for a preventive and unlimited Corrective Repair (Essentialcare or equal) service agreement for a Surface Plasmon Resonance (SPR) Biacore T200 instrument for a Base plus two (2) option years

Files

File Type Posted
75F40126Q134706-A00001.pdf PDF
75F40126Q134706.pdf PDF

Notice history

Similar open opportunities

On GovTribe

Work this opportunity

  • Track it in your pipeline
  • Find teaming partners
  • Similar opportunities
  • Ask GovTribe AI about this opportunity

GovTribe for Federal Contractors